Winton Matthew - Insider Trading & Ownership

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Winton Matthew
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2025-11-17
Purchase
2025-11-19
07:46 am
CervoMed Inc.CRVOWinton Matthew
Chief Commercial and Business
5,000$8.286$41,43015,000
(Direct)
View
2025-11-14
Purchase
2025-11-17
09:01 am
CervoMed Inc.CRVOWinton Matthew
Chief Commercial and Business
10,000$7.57$75,70010,000
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2025-10-06
Option Award
2025-10-08
4:07 pm
N/A
2035-10-06
CervoMed Inc.CRVOWinton Matthew
Chief Commercial and Business
75,000$075,000
(Direct)
View
2025-07-01
Equity Swap
2025-07-03
7:08 pm
N/A
N/A
Inozyme Pharma Inc.INZYWinton Matthew
COO
21,743$40
(Direct)
View
2025-06-25
Option Award
2025-06-27
4:05 pm
N/A
N/A
Inozyme Pharma Inc.INZYWinton Matthew
COO
14,355$0.7421,743
(Direct)
View
2025-03-31
Option Award
2025-04-02
4:29 pm
N/A
N/A
Inozyme Pharma Inc.INZYWinton Matthew
COO
2,490$0.777,388
(Direct)
View
2025-03-11
Option Award
2025-03-17
4:25 pm
N/A
2035-03-10
Inozyme Pharma Inc.INZYWinton Matthew
COO
186,500$0186,500
(Direct)
View
2024-09-30
Option Award
2024-10-03
8:57 pm
N/A
N/A
Inozyme Pharma Inc.INZYWinton Matthew
COO
1,710$4.454,898
(Direct)
View
2024-03-28
Option Award
2024-04-03
5:23 pm
N/A
N/A
Inozyme Pharma Inc.INZYWinton Matthew
COO
3,188$3.333,188
(Direct)
View
2024-03-13
Option Award
2024-03-15
08:30 am
N/A
2034-03-12
Inozyme Pharma Inc.INZYWinton Matthew
COO
175,000$0175,000
(Direct)
View
2023-04-03
Option Award
2023-04-04
08:35 am
N/A
2033-04-02
Inozyme Pharma Inc.INZYWinton Matthew
COO
250,000$0250,000
(Direct)
View